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ABSTRACT – This seminar discusses the history and development of tech-
niques for surgical intervention for people with refractory focal epilepsy.
Published surgical success rates and prognostic factors associated with
post-operative seizure freedom from individual studies have been vari-
able and contradictory. We present here the key ﬁndings of a Cochrane
systematic review of all evidence published since the introduction of mag-
netic resonance imaging (MRI) to pre-operative surgical assessment in 1984.
uncontrolled case series is now past.
rolleddesign should focuson speciﬁc
results and provide better-informed
section, systematic review
Where the origin of the seizures can
be localised discretely, surgery is a
validoption if thepotential beneﬁt is
assessed to outweigh the risk (Kwan
and Brodie, 2000).
Victor Horsley pioneered surgery as
a treatment for epilepsy (Feindel et
al., 2009). In 1886, he operated on
a 22-year-old man who had devel-
oped focal epilepsy following ahead
injury. A vascular scar was excised
along with a border of cortex that
resulted in cessation of the seizures.
Until the 1940s, surgerywas directed
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Future studieswith aprospective cont
research questions to help improve
advice.
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Epilepsy is a common condition
with a prevalence of around 1 in
200 people (Fisher et al., 2014).
Despite optimal pharmacotherapy,
about 20% to 30% of individuals do
not become seizure-free (Kwan and
Brodie, 2000). For some, surgery is
a therapeutic option. Focal seizures
originate within networks limited
to one hemisphere, which may be
discretely localized or more widely
distributed. They may originate in
subcortical structures (Berg et al.,
2010). The number of individualspileptic Disord, Vol. 18, No. 2, June 2016 113
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with focal epilepsy who do not
become seizure-free despite opti-
mal drug therapy varies according
to the age of the participants and
which focal epilepsies are included,
but has been reported as at least
20% and in some studies up to 70%.
mainly to the convexity of the cere-
bral hemispheres, most often for
the removal of traumatic scars and
tumours. Subsequently many other
causes of focal epilepsy have been
discoveredwhich are also amenable
to surgery.
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urgical techniques have been reﬁned over the
ears with the development of advanced methods
f pre-operative assessments, such as electroen-
ephalography (EEG) in the 1930s, computerized
omography in the 1970s, magnetic resonance imaging
MRI) in the 1990s, as well as computerised analy-
is of ictal and interictal EEG activity, functional MRI
ith psychometric analysis, and ever more sophis-
icated stereotaxis guiding the placement of deep
lectrodes for long-term EEG analysis and surgical
ntervention. Most recently, these techniques have
een complemented by the co-registration of sin-
le photon emission computed tomography (SPECT)
ndpositron emission tomography (PET) ﬁndings. This
pproach has led to more opportunity for the accu-
ate assessment of anypersonwithdrug-resistant focal
pilepsy and thusmoreopportunity for a surgical cure.
hey have also led to more precise localization of the
pileptogenic focus allowing for the removal of the
inimal amount of tissue, leading to a reduction in
ost-operative neurological deﬁcits.
eople began paying attention to the function of the
reas of the brain to be excised, becoming aware of
eﬁcits inﬂicteddespite a cureof theepilepsy.Notably,
t became clear that resection of the anteromesial
tructures of the temporal lobe produced short-term
emory impairment. Neuro-psychological assess-
ents have now become an important aspect of a
urgical work-up.
uccess rates for resective epilepsy surgery are esti-
ated to have increased from 43% to 85% during
he period 1986 to 1999 (National Institutes of Health
onsensusConference, 1990; Engel Jr et al., 1993; Engel
r et al., 2003). Data from multiple sources suggest
hat 55% to 70% of individuals undergoing temporal
esection and 30% to 50% of individuals undergoing
xtratemporal resection become completely seizure-
ree. Surgery is considered a valuable option for
edically intractable epilepsy, even in the absence
f proven drug resistance (Engel Jr and Shewmon,
993).
lthough it is known that surgical outcomes may be
reatly inﬂuenced by the presence of selected prog-
ostic indicators (Tonini et al., 1997; Berg et al., 1998), it
s still uncertain which people with a focal epilepsy
re most likely to achieve good surgical outcomes.
ood surgical outcomes appear to be associated with
number of factors (hippocampal sclerosis, anterior
emporal localisation of interictal epileptiform activ-14
ty, absence of pre-operative generalised seizures, and
bsence of seizures in the ﬁrst postoperative week)
McIntosh et al., 2001). However, the published trial
esults are frequently confusing and contradictory,
hus preventing inferences for clinical practice. We
herefore performed the ﬁrst Cochrane systematic
p
s
i
r
t
oeview to investigate the association between speciﬁc
rognostic factors and surgical outcome (West et al.,
015).
hat were the objectives of the
ochrane Review (West et al., 2015)?
he primary objective of the review was to assess
he proportion of individuals achieving a good out-
ome from surgery and the prevalence of unwanted
ffects.
he secondary objective was to identify prognos-
ic factors which were correlated with the outcome
f surgery. The prognostic factors of interest in this
eview were:
Pre-operative Factors
• Presence of normal pre-operative MRI results
• Use of pre-operative invasive monitoring
• Concordance of pre-operative MRI and EEG
• History of febrile seizures
• History of head injury
• Distribution of interictal spikes (unilateral or bilat-
eral)
Operative and post-operative factors
• Complete surgical resection
• Side of surgical resection (left or right)
• Presence of post-operative epileptiform dis-
charges
The following pathologies:
• Mesial temporal sclerosis (MTS)
• Encephalomalacia on pathology
• Focal cortical dysplasia ormalformationof cortical
development
• Tumour
• Vascular malformation
elevant studies were identiﬁed by searching MED-
INE (Ovid), the Cochrane Central Register of
ontrolled Trials, Cochrane Central Register of Con-
rolled Trials, ClinicalTrials.gov, and World Health
rganization (WHO) International Clinical Trials Reg-
stry Platform (ICTRP) from 1984 to July 2013.
e included studies of a randomised, cohort, case
ontrolor case seriesdesignwithanexpectedduration
f follow-up of at least one year, recruiting a sample
f surgical candidates of any age with a drug-resistant
pilepsy. For inclusion, at least 90% of patients had toEpileptic Disord, Vol. 18, No. 2, June 2016
leted in the era of computerised tomography) and
tudies had to report on a group of at least 30. Stud-
es must also have reported an outcome relating to
emission of seizures after surgery for inclusion; see
able 1 for accepted classiﬁcations of good and poor
utcomes for the review.
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Table 1. Deﬁnitions of seizure outcome following epilepsy surgery.
Outcome1 Deﬁnition Cochrane Review
outcome deﬁnition1
Engel Class Scale
Class 1: Free of disabling seizures
1A: Completely seizure-free since surgery
1B: Non-disabling simple partial seizures only since surgery
1C: Some disabling seizures after surgery, but free of disabling
seizures for at least 2 years
1D: Generalised convulsion with antiepileptic drug withdrawal only
Class 2 (rare disabling seizures ’almost seizure-free’)
Good outcome
Class 2: Almost seizure-free (rare disabling seizures)
2A: Initially free of disabling seizures but has rare seizures now
2B: Rare disabling seizures since surgery
2C: More than rare disabling seizures after surgery, but rare seizures
for at least 2 years
2D: Nocturnal seizures only
Poor outcome
Class 3: Worthwhile improvement
3A: Worthwhile seizure reduction
3B: Prolonged seizure-free intervals amounting to greater than half
the follow up
period, but not less than 2 years
Class 4: No worthwhile improvement
4A: No signiﬁcant seizure reduction
4B: No appreciable change
4C: Seizures worse
Seizure Freedom3
Seizure freedom for one year or more
Equivalent to Engel Class 1 for one year or more
Good outcome
No seizure freedom or seizure freedom for less than one year
Equivalent to Engel Class 2-4 or Engel Class 1 for less than one year
Poor outcome
International League
Against Epilepsy (ILAE)
Classiﬁcation3
Class 1: Completely seizure-free; no auras
Good outcome
Class 2: Only auras; no seizures
Class 3: One to three seizures per year; with or without auras
Poor outcome
Class 4: Four seizure days per year to 50% reduction of baseline
seizure days; with or without auras
Class 5: Less than 50% reduction of baseline seizure days to 100%
increase of baseline seizure days; with or without auras
Class 6: More than 100% increase of baseline seizure days; with or
1 of th
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Studies reporting other outcome scales or other combinations
All individuals must be classiﬁed as achieving a good or poor o
Classed as “Other” scale. Seizure freedom at two, three, four anpileptic Disord, Vol. 18, No. 2, June 2016
atient demographics, studydesign, andoutcomedata
ere extracted from published articles of all stud-
es. For individual factors of interest, studies were
ombined in ﬁxed-effects meta-analysis to assess the
resence or absence of that factor as an independent
p
(
p
p
se scales above were not included in analysis of the review.
e of surgery for comparison in the review.
e years also included as “Other” outcome scales.115
redictor of the outcome of surgery. Heterogeneity
variability) between studies was assessed by com-
aring study characteristics, visually inspecting forest
lots, and using the I2 statistic as a measure of incon-
istency across studies. Random-effects meta-analysis
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as also performed as a sensitivity analysis if consid-
rable heterogeneity was present in statistical analysis
I2 greater than 50%) (Higgins and Green, 2011).
hat were the ﬁndings of the Cochrane
eview (West et al., 2015)?
tudy design and quality
n total, 177 studies with 16,508 patients undergoing
urgery were identiﬁed as eligible for the Cochrane
eview (see West et al. [2015] for the list of included
tudies). Four studies of a prospective randomised
esign were included; three randomising the type
r length of surgical resection and one randomising
atients to surgery or antiepileptic drug treatment.
urgery was found to be superior to antiepileptic
rug treatment (risk ratio [RR]: 7.67; 95% conﬁdence
nterval [CI]: 2.50 to 23.51; 80 patients; Wiebe et al.
2001]); 23 out of 40 receiving surgery achieved free-
om from seizures that impaired awareness after one
ear, compared to three out of 40 medically treated
atients. Total hippocampectomy was found to be
uperior to partial hippocampectomy (RR: 1.82; 95%
I: 1.12 to 2.93; 70 patients; Wyler et al. [1995]) in terms
f seizure freedom at one year. No differences were
ound between 2.5-cm and 3.5-cm resections (RR: 1.02;
5%CI: 0.86 to 1.20; 207 patients; Schramm et al. [2011])
r between anterior temporal lobectomy with and
ithout corpus callosotomy (RR: 1.22; 95% CI: 0.85 to
.76; 60 patients; Liang et al. [2010]) in terms of seizure
reedom at one or two years, respectively.
he remaining studies were non-randomised; 17 were
rospective and the remaining 156 were retrospective
r of unclear design. None of these studies included a
ontrol group for the surgical intervention group. See
able 2 for details of all study characteristics.
uality was assessed for all included studies using the
ochrane Risk of Bias tool (Higgins and Green, 2011)
or randomised studies and the Effective Public Health
ractice Project (EPHPP) tool (Thomas et al., 2004)
or non-randomised studies. Criteria considered were
tudydesign, presenceof blinding, selectionbias, con-
ounding data collection, incomplete outcome data,
ntervention integrity and analysis. The majority of
tudies were judged to be ofmoderate or weak quality
ue to non-randomised design. This poor qualitymust
e taken into account when interpreting the results of16
he Cochrane Review.
urgical outcome and relation to prognostic
actors
n total, 10,518 patients (65%) out of 16,253 con-
ributing to the analysis achieved a good outcome
r
a
o
s
o
T
Af surgery (table 2). Outcome of surgery, according
o the presence of the prognostic factors of inter-
st, is summarised in table 3. Presence of mesial
emporal sclerosis or tumour on pathology, concor-
ant pre-operative MRI and EEG, history of febrile
eizures, unilateral interictal spikes, and complete
urgical resection were shown to be independent pre-
ictors of a good outcome of surgery, while normal
re-operativeMRI, the need to use pre-operative inva-
ivemonitoring, presenceof focal cortical dysplasia, or
alformation of cortical development on pathology
nd left-sided resection were shown to be indepen-
ent predictors of poor outcome of surgery. History of
ead injury, presenceof encephalomalacia, or vascular
alformation onpathology andpost-operative epilep-
iform discharges were not shown to be independent
redictors of seizure outcome.
afety of surgical resection
he reporting of adverse events was inadequate, with
nly 74 out of the 177 included studies (42%) reporting
nmortality andmorbidity following epilepsy surgery.
dverse events were recorded for 1,308 (14%) of the
,512 participants involved in these 74 studies. The
umber of adverse events occurring per person was
ot speciﬁed. Events were deﬁned as follows (with
ercentage of 1,308 total events):
ndeﬁned: 98 (7.5%); infection/fever: 251 (19.2%);
otor impairment (mono-, hemi-, facial pareses along
ith cranial nerve involvement): 220 (16.8%); visual
eld defect: 173 (13.2%); haemorrhage: 56 (4.3%); lan-
uage impairment: 42 (3.2%); CSF leak or collection: 36
2.8%); cognitive impairment to include memory loss:
4 (2.6); hydrocephalus: 24 (1.8%); and miscellaneous
includingdeepvenous thrombosis, statusepilepticus,
erebral oedema and urinary incontinence): 10 (0.8%).
etail of reporting including timing and duration of
vent, relation to surgery, and severity of event (tran-
ient effect, permanent deﬁcit, or death)was very poor
nd few studies made any reference to postoperative
ognition, quality of life, or mental state.
iscussion of the ﬁndings of the
ochrane review (West et al., 2015)
he 177 included studies were of variable size and
esign, were conducted in a range of countries, andEpileptic Disord, Vol. 18, No. 2, June 2016
ecruited a wide range of participants of different ages
nd with different durations of epilepsy. A wide range
f surgical techniques were carried out across these
tudies and different scales were used to measure the
utcome of surgery.
he recent consensus from the International League
gainst Epilepsy, Kwan et al. (2010), proposes that a
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Table 2. Summary of study characteristics, patient characteristics and overall seizure outcome.
Characteristic or
demographic
Number of studies and
patient information
available for [n (%)]
Summary of characteristic or demographic1
Gender 149 studies (84%)
13,360 patients (81%)
7,591 male patients (57%)
Age at surgery 152 studies (86%)
13,801 patients (84%)
Range: 0 to 86 years
Age group recruited
into study
152 studies (86%)
13,801 patients (84%)
Adults only: 28 studies (18%); 2,285 patients (17%)
Children only: 21 studies (14%); 1,147 patients (8%)
Both: 103 studies (68%); 10,374 patients (75%)
Duration of epilepsy 110 studies (62%)
10,391 patients (63%)
Range: 0 to 86 years
Type(s) of surgical
resection performed
168 studies (95%)
15,661 patients (95%)
Temporal lobe only: 76 studies (45%); 7,942 patients (51%)
Extratemporal lobe only: 15 studies (9%); 1,058 patients (6%)
Both types: 77 studies (46%); 6,661 patients (43%)
Study design 168 studies (95%)
15,771 patients (96%)
Prospective (randomised): 4 studies (2%); 373 patients (2%)
Prospective (non-randomised): 17 studies (11%); 1,499
patients (10%)
Retrospective (non-randomised): 144 studies (86%); 13,557
patients (86%)
Prospective and retrospective (non-randomised): 3 studies
(1%); 342 patients (2%)
Outcome scale used2 177 studies (100%)
16,508 patients (100%)
Engel Class Scale: 117 studies (65%); 10,619 patients (64%)
More than one year seizure-free: 42 studies (24%); 3,981
patients (24%)
Other scale: 18 studies (11%); 1,908 patients (12%)
Follow-up of studies 177 studies (100%)
16,508 patients (100%)
Range: 0 to 366 months
Seizure outcome2 173 studies (98%)
16,253 patients (98%)
Proportion achieving a good outcome: 10,518 patients (65%)
Range across studies: 13.5%-92.5% achieving a good
outcome.
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Summary statistics including percentages are based on the info
See Table 1 for deﬁnition of outcome scales.
See West et al. (2015) for reference list of included studies.
reatment’s success should be deﬁned by sustained
reedom from seizures, as that is the only efﬁcacy
utcome consistently associated with improved qual-
ty of life (and in the UK, the only efﬁcacy outcome
hat allows a patient to drive legally). This justiﬁes ourpileptic Disord, Vol. 18, No. 2, June 2016
ocus on at least 12 months’ seizure freedom in this
eview.
e found the reporting of related adverse events
o be sparse and very poor; complications and/or
urgery-related deaths were reported in less than half
f included studies, often lacking speciﬁc detail of
w
i
1
d
F
gion available.
he nature and consequence of the event (transient
r permanent) and the timing of events. Few studies
ontained any reference to postoperative cognition or
ental state.
rom the data available, the message for the clinician117
hen consulted by a person with intractable epilepsy,
s clear. If selection criteria are met, there is a 1 in
1 chance of improvement with the next antiepileptic
rug and a 2 in 3 chance of improvement with surgery.
urthermore, we have observed that, overall, the sur-
ical procedures have a low complication rate. This
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Table 3. Prognostic factors for a good outcome of surgery in all included studies.
Prognostic factor
of interest
Number of studies
(patients) reporting
prognostic factor
Proportion with a good outcome
Risk Ratio (95% CI)1
Factor present Factor absent
Normal MRI 42 (3,956) 687/1,252 (55%) 1,816/2,704 (67%) 0.78 (0.73, 0.82)
Use of intracranial
monitoring
21 (1,547) 448/762 (59%) 564/785 (72%) 0.85 (0.78, 0.93)
Mesial temporal sclerosis
on pathology
46 (4,430) 1,340/1,796 (75%) 1,663/2,634 (63%) 1.17 (1.12, 1.23)
Concordant preoperative
MRI and EEG
23 (1,778) 824/1,200 (69%) 313/578 (54%) 1.25 (1.15, 1.37)
History of febrile seizures 15 (1,368) 343/440 (78%) 615/928 (66%) 1.09 (1.01, 1.17)
History of head injury 7 (551) 100/159 (63%) 242/392 (62%) 0.99 (0.86, 1.13)
Encephalomalacia on
pathology
4 (274) 9/35 (26%) 90/239 (38%) 0.67 (0.37, 1.21)
Focal cortical dysplasia or
malformation of cortical
development on
pathology
45 (3,529) 672/1,183 (57%) 1,584/2,346 (68%) 0.90 (0.85, 0.95)
Tumour on pathology 41 (3,357) 595/806 (74%) 1,512/2,551 (59%) 1.23 (1.14, 1.32)
Vascular malformation on
pathology
19 (1,488) 89/139 (64%) 785/1,349 (58%) 1.07 (0.94, 1.21)
Unilateral interictal spikes 18 (1,414) 504/732 (69%) 406/682 (60%) 1.14 (1.05, 1.24)
Complete surgical
resection
40 (3,013) 1,277/1,716 (74%) 725/1,297 (56%) 1.41 (1.32, 1.50)
Left-side surgical
resection
36 (2,933) 988/1,479 (67%) 1,041/1,454 (72%) 0.94 (0.90, 0.98)
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epileptiform discharges
6 (542) 132/2
Risk ratios in italics are statistically signiﬁcant. Risk ratio greater
utcome of surgery and risk ratio less than 1 indicates the pres
bsence of the factor is associated with a good outcome of surge
s in line with other reports showing that less than
% of patients have permanent post-operative neu-
ological deﬁcits secondary to accidental damage of
entral nervous system (CNS) tissue (Engel Jr, 1996;
ngel Jr et al., 2003). The percentage adverse event
revalence of 7.3% is highly likely to be an over-18
stimate of the prevalence of permanent neurological
eﬁcit, as many studies did not record which events
ere only transient andmore than one event could be
ecorded in the same person. We should emphasise
hat very few studies addressed the important issue
f formally reassessing any postoperative impairment
f cognition, speech and language, social function-
l
w
t
s
s
T
a(66%) 262/342 (77%) 0.91 (0.68, 1.22)
1 indicates the presence of the factor is associated with a good
of the factor is associated with a poor outcome of surgery (i.e.
ng, or altered mental state (all linked to quality of
ife). This aspect should bewritten into future research
rotocols.
he extent of resection was the strongest determinant
f outcome in our review, particularly with extratem-
oral surgery. The dilemma for the surgeon is thatEpileptic Disord, Vol. 18, No. 2, June 2016
arger areas of resection are likely to be associated
ith a higher complication risk. The extent of resec-
ion is affected by the underlying pathology, the site of
urgery, and the development of investigational and
urgical procedures.
he good outcome associated with the presence of
bnormalMRI is expectedandprobably largely reﬂects
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6.variety of CNS conditions, which we know are
ssociated with a good prognosis, such as tumours,
esial temporal sclerosis (MTS), and many congenital
alformations. These are discrete structural lesions
hat lend themselves to complete resection. For exam-
le, tumours carried a higher chance of seizure
emission at 12 months than other CNS disorders (RR
f presence versus absence for 12-month remission:
.23; 95% CI: 1.14 to 1.32). Non-speciﬁc or ill-deﬁned
on-tumoural lesions, e.g. whitematter abnormalities,
re less easy to delineate. Thus, they are less easy to
esect completely without causing signiﬁcant damage.
his results in a poor surgical outcome.
reasonable prospect of seizure freedom is not
uled out with normal MRI. Jayakar et al. (2008)
eport on a cohort (predominantly of children) with
on-lesional intractable focal epilepsy undergoing
esective surgery. After two years of follow-up, 44 of
01 participants were seizure-free. Factors that cor-
elated with good outcome were the presence of
onvergent scalp EEG, focal interictal spikes (p<0.005),
nd completeness of resection (p<0.0005). Dorward
t al. (2011) studied children with extratemporal, non-
esional epilepsy.Outcomewasclassiﬁedas Engel class
or 2 in 54.5% of the children who underwent resec-
ion of the lesion or multiple sub-pial resections. The
esultswereobtained through theuseof invasivemon-
toring with grid/strip electrodes.
here is a strong association between MTS and a his-
ory of febrile seizures. The term “mesial temporal
clerosis” as an alternative to “hippocampal sclero-
is” was introduced in recognition of the frequent
nvolvement ofmesial limbic structures adjacent to the
ippocampus. Neocortical neuronal loss and gliosis
temporal lobe sclerosis [TLS]) was studied by Thom
t al. (2009), who identiﬁed TLS in 30 of 272 surgically
reated cases of hippocampal sclerosis. There was a
istory of a febrile seizure as an initial event in 73%
f patients with TLS compared with 36% without TLS.
ebrile status was seen in 27% of the febrile seizures.
he changes of TLS may be due to an enhanced vul-
erability of superﬁcial cortical neurons in maturing
eocortex, from an early cerebral event in a small
roup of children. The good outcome associated with
history of febrile seizures can be interpreted in the
ight of its association with a mesial temporal sclerosis
eing a more readily selectable lesion.
EG/MRI concordance is correlated with a better sur-
ical outcome, although it is clear that results willpileptic Disord, Vol. 18, No. 2, June 2016
epend very much on the mix of pathologies under-
ying the epilepsy. Studies containing a large number
ith discrete lesions, such as tumours, are likely to
how more concordance and a better outcome than
tudies with a predominance of less discrete lesions,
s can be the case with many neurodevelopmental
bnormalities.
r
p
o
e
t
d
iSurgery for epilepsy
he need for intracranial monitoring itself implies that
here is uncertainty in the location and extent of an
pileptogenic zone, often accompanied by indeter-
inate neuroimaging. The association between the
eed for intracranial monitoring and a poor outcome
s therefore not surprising. In these cases, fewer than
0% may become seizure-free, postoperatively. Poor
ocalisation is also reﬂected in the fact that partici-
ants with unilateral interictal spikes are signiﬁcantly
ore likely to achieve a good outcome of surgery than
articipants with bilateral interictal spikes. The persis-
ence of postoperative discharges is likely to reﬂect
hese very same issues. There are units that will re-
perate very quickly when postoperative discharges
re identiﬁed. The heterogeneity of our results does
ot allow us to support this approach. It is but one
xample of how properly conducted research should,
n the future, help determine the appropriate care
athway (see below).
here are limitations to this review. These include the
act that studies report different criteria for seizure
utcome and a variable length of follow-up, and have
etrospective designs that increase the risk of bias in
ata collection. In addition, variables that could affect
utcome were examinedmostly in univariate analyses
ithout considering the effects of other prognostic
eatures or confounders. Despite these limitations,
ur results provide some clinical guidance for the
election of the best surgical candidates. The criteria
dopted to identify the indications and the appli-
ations of epilepsy surgery are constantly evolving.
ontinuingattemptsneed tobemade todeﬁnepatient
nd procedure-related prognostic indicators.
e do feel that further studies with a prospective
esign are needed to help improve results and hence
rovide better-informed advice. It seems that the use-
ulness of yet another uncontrolled case series is now
ast. For the future, the primary outcome measure for
ntervention studiesought tobe seizure freedomat set
ime points with a minimum of one year of follow-up.
ssessment should be blinded and linked to quality of
ifemeasurement. The design should be a randomised
ontrolled trial, appropriately powered with a focus
n speciﬁc research questions that remain as unan-
wered today by this large body of literature as they
id when Victor Horsley helped the young Scot in
886.
here are many questions to answer but they should
ddress the issues of extent of resection for tempo-119
al and extratemporal lesions, the deﬁnition of care
athways for the most cost-efﬁcient and effective pre-
perative selection, intervention for non-lesional focal
pilepsy, bilateral and postoperative spikes, and when
o tail antiepileptic drugs, among many others. Clear
ata on risks (adverse events, their nature, and tim-
ng), as well as beneﬁts, should always be recorded.
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rotocols should include pre- and postoperative mea-
ures of speech and language, cognition and social
unctioning, along with a mental state assessment.
here will be methodological difﬁculties and ade-
uate powering will require multi-centre approaches.
mprovements in the development of cancer care over
he past three to four decades have been achieved
y answeringwell-deﬁned questions through the con-
uct of focused RCTs in a step-wise fashion. The same
pproach to surgery for epilepsy is required. 
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Surgery for epilepsy
TEST YOURSELF
EDUCATION
(1) Which of the following are associated with improved surgical outcome?
A. Presence of mesial temporal sclerosis or tumour
B. Concordant pre-operative MRI and EEG
C. History of febrile seizures
D.Unilateral interictal spikes
E . Complete surgical resection
(2) There has been one published trial (Wiebe et al., 2001) randomising participants to surgery or antiepileptic
drug treatment. Based on the results of this trial, howmany individuals per 1,000would be expected to achieve
freedom from seizures which impair awareness after one year:
A. When receiving medical treatment?
B. When receiving surgery?
(3) Whichof the following shouldbe included in themethodologyof future studiesonestablishing thebeneﬁt,
or otherwise, of surgical intervention for people with an intractable epilepsy.
A. Primary outcome measure of seizure freedom at set time points
B. Minimum of one year of follow-up
C. Assessment should be blinded
D. Quality of life measurement included
E . Randomised controlled trial design
F . Powered appropriatelypileptic Disord, Vol. 18, No. 2, June 2016 121
G. Pre- and postoperative measures of speech and language, cognition, and social functioning
H. Pre- and postoperative measures of mental state assessment
Note: Reading the manuscript provides an answer to all questions. Correct answers may be accessed on the
website, www.epilepticdisorders.com, under the section “The EpiCentre”.
